Hasbani Follows Up The Death Of Farah Kassab And Issues Two Decisions And Two Letters To The General

Hasbani Follows up the Death of Farah Kassab and Issues Two Decisions and Two Letters to the General Prosecution and the Order of Physicians

The Information Office of Deputy Prime Minister Health Minister Ghassan Hasbani issued the following statement:

In the context of following up the death of Farah Kassab after she underwent a cosmetic surgery in a specialized hospital in cosmetic surgeries,

Health Minister Ghassan Hasbani took the following actions:

The issuance of a decision on the prevention of surgical operations that require a general anesthetic in day hospitals or other cosmetic surgery clinics.
The issuance of a decision on the prevention of surgical operations that require a general anesthetic in Dr. Nader Saab hospital specialized in cosmetic surgery.
The issuance of a letter to the Public Prosecutor to investigate into the death of Farah Kassab.
The issuance of a letter to the Lebanese Order of Physicians in Beirut to conduct necessary investigations into the death of Farah Kassab, and give the Order a period of two weeks to clarify some technical medical points and answer questions asked by Health Minister concerning the death of the said woman.

These steps came to complete the immediate oral decision of Health Minister Ghassan Hasbani to cease operations in the said clinic after the woman's death, and the written decision issued Friday 2 June 2017 which stipulates the following:

Surgeries that may cause complications that require intensive care like liposuction and other surgeries shall not performed in places other than specialized hospitals which include an intensive care division that holds a license form Health Ministry in accordance with due process.
The doctor should explain to the patient the risks of the surgery, including the plastic surgery, and ask the patient to sign the Patient Right Form and the informed consent.

...

All

ATC	Name	B/G	Ingredients ↓	Dosage	Form	Price
G04BE30	LIF-DOL	B	Yohimbin HCl - 3.3mg, Thiamine - 5.5mg, Cyanocobalamine - 0.015mg, Ferrous fumarate - 50mg, Sildenafil citrate - 10mg		Tablet, coated	231,653 L.L
N06AX26	LYTIOX	G	Vortioxetine - 5mg	5mg	Tablet, film coated	1,270,379 L.L
N06AX26	LYTIOX	G	Vortioxetine - 20mg	20mg	Tablet, film coated	3,290,622 L.L
N06AX26	LYTIOX	G	Vortioxetine - 10mg	10mg	Tablet, film coated	2,064,142 L.L
G04BE09	LEVIDOR	G	Vardenafil (HCl) - 5mg	5mg	Tablet	876,185 L.L
G04BE09	LEVITRA	B	Vardenafil (HCl) - 20mg	20mg	Tablet, film coated	2,660,808 L.L
G04BE09	LEVIDOR	G	Vardenafil (HCl) - 20mg	20mg	Tablet	401,809 L.L
C09DX01	LOTEVAN PLUS	G	Valsartan - 160mg, Amlodipine - 5mg, Hydrochlorothiazide - 12.5mg		Tablet, film coated	857,372 L.L
C09DX01	LOTEVAN PLUS	G	Valsartan - 160mg, Amlodipine - 10mg, Hydrochlorothiazide - 12.5mg		Tablet, film coated	911,125 L.L
B05BA02	LIPIDEM	G	Triglycerides, Medium Chain - 100g/500ml, Soya bean oil - 80g/500ml, Omega-3 acid triglicerides - 20g/500ml		Injectable emulsion	2,486,109 L.L
L01BC59	LONSURF	B	Trifluridine - 20mg, Tipiracil - 8.19mg		Tablet, film coated	75,019,126 L.L
L01BC59	LONSURF	B	Trifluridine - 15mg, Tipiracil - 6.14mg		Tablet, film coated	58,102,683 L.L
N02AJ14	LENIZAK	B	Tramadol HCl - 75mg, Dexketoprofen - 25mg		Tablet, film coated	494,534 L.L
S01ED51	LOPROSTAN	G	Timolol - 5mg/ml, Latanoprost - 50μg/ml		Drops	768,678 L.L
G03CX01	LIVIAL	B	Tibolone - 2.5mg	2.5mg	Tablet	1,135,547 L.L
D01BA02	LAMIFEN	G	Terbinafine HCl - 250mg	250mg	Tablet	245,923 L.L
D01BA02	LAMINOX	G	Terbinafine HCl - 250mg	250mg	Tablet	725,675 L.L
D01AE15	LAMISIL	B	Terbinafine HCl - 10mg/ml	1%	Solution	506,629 L.L
D01AE15	LAMISIL	B	Terbinafine HCl - 10mg/g	1%	Cream	616,824 L.L
D01AE15	LAMINOX	G	Terbinafine HCl - 10mg/g	10mg/g	Cream	453,067 L.L
D01AE15	LAMIFEN	G	Terbinafine HCl - 1%	1%	Cream	350,743 L.L
G04BE08	LINK	G	Tadalafil - 5mg	5mg	Tablet, film coated	3,926,708 L.L
G04BE08	LINK	G	Tadalafil - 20mg	20mg	Tablet, film coated	1,374,751 L.L
G04BE08	LINK	G	Tadalafil - 20mg	20mg	Tablet, film coated	369,557 L.L
J07CA	LANTIGEN B	B	Streptococcus pneumoniae type 3 (antigenic extracts) - 63.2A.U./ml, Streptococcus pyogenes group A (antigenic extracts) - 126.2A.U./ml, Branhamella catarrhalis (antigenic extracts) - 39.9A.U./ml, Staphylococcus aureus (antigenic extracts) - 79.6A.U./ml, Haemophilus influenzae type b (antigenic extracts) - 50.2A.U./ml, Klebsiella pneumoniae (antigenic extracts) - 39.8A.U./ml		Drops suspension	916,501 L.L
B05BB01	LACTATED RINGER'S INJECTION, USP	G	Sodium lactate - 3.1g/l, Calcium chloride, 2H2O - 0.2g/l, Potassium chloride - 0.3g/l, Sodium chloride - 6g/l		Injectable solution	158,587 L.L
B05BB01	LACTATED RINGER'S INJECTION, USP	G	Sodium lactate - 3.1g/l, Calcium chloride, 2H2O - 0.2g/l, Potassium chloride - 0.3g/l, Sodium chloride - 6g/l		Injectable solution	216,046 L.L
B05BB01	LACTATED RINGER'S INJECTION, USP	G	Sodium lactate - 3.1g/l, Calcium chloride, 2H2O - 0.2g/l, Potassium chloride - 0.3g/l, Sodium chloride - 6g/l		Injectable solution	232,134 L.L
B05BB01	LR	G	Sodium lactate - 0.3g/100ml, Calcium chloride, 2H2O - 0.02g/100ml, Potassium chloride - 0.03g/100ml, Sodium chloride - 0.598g/100ml		Injectable solution	234,862 L.L
B05BB01	LACTATED RINGER'S INJECTION USP	G	Sodium lactate - 0.31g/100ml, Calcium chloride, 2H2O - 0.02g/100ml, Potassium chloride - 0.03g/100ml, Sodium chloride - 0.6g/100ml		Injectable solution	197,659 L.L

...